The complete nucleotide sequence of the multi-drug resistance-encoding IncL/M plasmid pACM1

Karen E Preston1, Sandra A Hitchcock2, Abdullah Y Aziz2

  • 1Center for Functional Genomics, University at Albany, SUNY, 1 Discovery Dr., Rensselaer, NY 12144-3452, USA.

Plasmid
|October 8, 2014
PubMed

Insights

The pACM1 plasmid, carrying cephalosporin resistance genes, was sequenced. Its multi-drug resistance region is unique, and its plasmid copy number was measured using qPCR, providing insights into antibiotic resistance.

Area of Science:

  • Microbiology
  • Genomics
  • Molecular Biology

Background:

  • The pACM1 plasmid was isolated from a cephalosporin-resistant Klebsiella oxytoca strain in 1993.
  • Plasmid sequence data is crucial for understanding antibiotic resistance mechanisms.

Purpose of the Study:

  • To complete and analyze the nucleotide sequence of the pACM1 plasmid.
  • To characterize the multi-drug resistance (MDR) region of pACM1.
  • To measure the plasmid copy number (PCN) of pACM1 using a novel qPCR assay.

Main Methods:

  • Whole-genome sequencing of the pACM1 plasmid.
  • Bioinformatic analysis to identify resistance genes and genetic elements.
  • Quantitative Polymerase Chain Reaction (qPCR) assay to determine PCN.

Main Results:

  • The 89,977 bp sequence of pACM1 (GenBank accession KJ541681) was determined, featuring a unique 31,842 bp MDR region with multiple resistance cassettes and transposons.
  • The MDR region contains mer, integrons, IS1R, IS26, and Tn2003 (blaSHV-5) within a Tn1721-like element inserted into the mucB gene of an IncL/M plasmid.
  • The PCN of pACM1 was found to be approximately three copies per chromosome in E. coli DH5α and two copies in the original K. oxytoca isolate.

Conclusions:

  • The pACM1 plasmid possesses a unique MDR region, distinct from other sequenced IncL/M plasmids.
  • The developed qPCR assay provides a reliable method for determining PCN, which influences resistance gene dosage.
  • Further studies on PCN and its impact on resistance levels are facilitated by complete genome sequences and qPCR technology.